tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TIL Stock Latest News

Instil Bio’s AXN-2510: Promising Data and Valuation Gap Justify Buy Rating
RatingsInstil Bio’s AXN-2510: Promising Data and Valuation Gap Justify Buy Rating
9d ago
TIL
Instil Bio announces ImmuneOnco presentation of ‘2510 monotherapy data
PremiumThe Fly
Instil Bio announces ImmuneOnco presentation of ‘2510 monotherapy data
10d ago
TIL
Instil Bio’s Promising Outlook: Buy Rating Supported by Successful Trials and Market Potential
PremiumRatings
Instil Bio’s Promising Outlook: Buy Rating Supported by Successful Trials and Market Potential
24d ago
TIL
Instil Bio Receives Buy Rating Amid Promising Trial Data and Strong Financial Outlook
PremiumRatings
Instil Bio Receives Buy Rating Amid Promising Trial Data and Strong Financial Outlook
1M ago
TIL
Instil Bio Reports Promising Phase 2 Study Results
PremiumCompany Announcements
Instil Bio Reports Promising Phase 2 Study Results
2M ago
8K
TIL
Instil Bio: ImmuneOnco reports results from Phase 2 study of IMM2510/AXN-2510
PremiumThe FlyInstil Bio: ImmuneOnco reports results from Phase 2 study of IMM2510/AXN-2510
2M ago
TIL
Instil Bio announces FDA clearance of IND application for AXN-2510
Premium
The Fly
Instil Bio announces FDA clearance of IND application for AXN-2510
3M ago
TIL
Instil Bio adds Maraganore to the Board of Directors of Axion Bio
Premium
The Fly
Instil Bio adds Maraganore to the Board of Directors of Axion Bio
3M ago
TIL
Instil Bio Positioned as a Promising Player in the PD-1/L1 x VEGF Market with Strong Buy Recommendation
PremiumRatings
Instil Bio Positioned as a Promising Player in the PD-1/L1 x VEGF Market with Strong Buy Recommendation
4M ago
TIL
Instil Bio appoints Jamie Freedman as CMO
PremiumThe Fly
Instil Bio appoints Jamie Freedman as CMO
4M ago
TIL
Instil Bio Elects Director and Ratifies Auditor
PremiumCompany Announcements
Instil Bio Elects Director and Ratifies Auditor
4M ago
8K
TIL
Instil Bio Advances Phase 2 Trial in China
PremiumCompany Announcements
Instil Bio Advances Phase 2 Trial in China
4M ago
8K
TIL
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
4M ago
TIL
IMNN
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
CVM
TIL
Instil Bio price target raised to $125 from $105 at H.C. Wainwright
Premium
The Fly
Instil Bio price target raised to $125 from $105 at H.C. Wainwright
4M ago
TIL
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
TIL
ARMP
Instil Bio Partners with ImmuneOnco for Cancer Therapy
PremiumCompany Announcements
Instil Bio Partners with ImmuneOnco for Cancer Therapy
4M ago
8K
TIL
Instil Bio price target lowered to $105 from $110 at H.C. Wainwright
PremiumThe Fly
Instil Bio price target lowered to $105 from $110 at H.C. Wainwright
4M ago
TIL
Instil Bio’s Phase 2 trial of asset AXN-2510 to complete enrollment in China
PremiumThe Fly
Instil Bio’s Phase 2 trial of asset AXN-2510 to complete enrollment in China
4M ago
TIL
Instil Bio reports Q1 EPS ($1.32) vs ($2.39) last year
PremiumThe FlyInstil Bio reports Q1 EPS ($1.32) vs ($2.39) last year
4M ago
TIL
Instil Bio’s Promising Pipeline and Strategic Collaborations Drive Buy Rating
Premium
Ratings
Instil Bio’s Promising Pipeline and Strategic Collaborations Drive Buy Rating
7M ago
TIL
Instil Bio Reports 2024 Financial Results and Outlook
Premium
Company Announcements
Instil Bio Reports 2024 Financial Results and Outlook
7M ago
8K
TIL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >